Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today
Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today

We deliver Mobile Wallet Market Research and SWOT Analysis from Alternative Energy to Pharmaceuticals and Healthcare Market Research Reports to Digital Media.

Skip to Main Content »

Search Site
Researchers Currently Online:1023

Enzo Biochem, Inc. (ENZ) - Financial and Strategic SWOT Analysis Review

Enzo Biochem, Inc. (ENZ) - Financial and Strategic SWOT Analysis Review

Double click on above image to view full picture

Zoom Out
Zoom In
Additional Information
Price $125.00
Meta Description Enzo Biochem, Inc. (Biochem) is an integrated life sciences and biotechnology company. It harnesses biological processes to develop research tools, diagnostics and therapeutics. The company focuses on the development of technologies in research, developme
Publisher GlobalData
Date of Report Dec 3, 2013
Quick Overview
Summary

Enzo Biochem, Inc. (Biochem) is an integrated life sciences and biotechnology company. It harnesses biological processes to develop research tools, diagnostics and therapeutics. The company focuses on the development of technologies in research, development, manufacture, licensing and commercializating of innovative health care products, platforms and services based on molecular and cellular technologies.

Enzo Biochem, Inc. Key Recent Developments

Nov 02, 2012: Enzo Awarded $49m In Trial Against Applera
Oct 15, 2012: Enzo Biochem Reports Revenue Of $26.4m In Q4 Fiscal 2012
Jun 11, 2012: Enzo Biochem Reports Revenue Of $25.9m In Q3 Fiscal 2012
Mar 20, 2012: Enzo Biochem Expands Distribution Agreement With Cosmo Bio
Mar 12, 2012: Enzo Biochem Reports Revenue Of $25m In Q2 Fiscal 2012GDPH57980FSA

This comprehensive SWOT profile of Enzo Biochem, Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Section 1 - About the Company 5
Enzo Biochem, Inc. - Key Facts 5
Enzo Biochem, Inc. - Key Employees 6
Enzo Biochem, Inc. - Key Employee Biographies 7
Enzo Biochem, Inc. - Major Products and Services 8
Enzo Biochem, Inc. - Pharmaceutical Pipeline Products Data 9
Enzo Biochem, Inc., Pipeline Products by Therapy Area 9
Enzo Biochem, Inc., Pipeline Products by Development Phase 10
Enzo Biochem, Inc. - History 12
Enzo Biochem, Inc. - Company Statement 14
Enzo Biochem, Inc. - Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Section 2 – Company Analysis 19
Enzo Biochem, Inc. - Business Description 19
Enzo Biochem, Inc. - SWOT Analysis 20
SWOT Analysis - Overview 20
Enzo Biochem, Inc. - Strengths 20
Strength - Strong Intellectual Property Base 20
Strength - Strong Technological Base 20
Strength - Diversified Offerings 20
Enzo Biochem, Inc. - Weaknesses 20
Weakness - Revenue Concentration 20
Weakness - Decreasing Operational Efficiency 21
Enzo Biochem, Inc. - Opportunities 21
Opportunity - Major Products under Development 21
Opportunity - Changing Demographics 21
Opportunity - Emerging Markets 21
Enzo Biochem, Inc. - Threats 22
Threat - Increasing Competitive Pressures 22
Threat - Uncertainties in R&D 22
Threat - Stringent Government Regulations 22
Enzo Biochem, Inc. - Key Competitors 23
Section 3 – Company Financial Ratios 24
Financial Ratios - Capital Market Ratios 24
Financial Ratios - Annual Ratios 24
Performance Chart 26
Financial Performance 26
Financial Ratios - Interim Ratios 27
Financial Ratios - Ratio Charts 28
Section 4 – Company’s Lifesciences Financial Deals and Alliances 29
Enzo Biochem, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 29
Enzo Biochem, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013 30
Enzo Biochem, Inc., Recent Deals Summary 31
Section 5 – Company’s Recent Developments 32
Enzo Biochem, Inc., Recent Developments 32
Nov 02, 2012: Enzo Awarded $49m In Trial Against Applera 32
Oct 15, 2012: Enzo Biochem Reports Revenue Of $26.4m In Q4 Fiscal 2012 32
Jun 11, 2012: Enzo Biochem Reports Revenue Of $25.9m In Q3 Fiscal 2012 33
Mar 20, 2012: Enzo Biochem Expands Distribution Agreement With Cosmo Bio 33
Mar 12, 2012: Enzo Biochem Reports Revenue Of $25m In Q2 Fiscal 2012 34
Mar 08, 2012: Enzo Biochem To Present New AmpiProbe Nucleic Acid Amplification Platform At ESCMID London Meeting 34
Section 6 – Appendix 36
Methodology 36
Ratio Definitions 36
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
Enzo Biochem, Inc., Key Facts 5
Enzo Biochem, Inc., Key Employees 6
Enzo Biochem, Inc., Key Employee Biographies 7
Enzo Biochem, Inc., Major Products and Services 8
Enzo Biochem, Inc., Number of Pipeline Products by Therapy Area 9
Enzo Biochem, Inc., Number of Pipeline Products by Development Stage 10
Enzo Biochem, Inc., Pipeline Products By Therapy Area and Development Phase 11
Enzo Biochem, Inc., History 12
Enzo Biochem, Inc., Other Locations 17
Enzo Biochem, Inc., Subsidiaries 18
Enzo Biochem, Inc., Key Competitors 23
Enzo Biochem, Inc., Ratios based on current share price 24
Enzo Biochem, Inc., Annual Ratios 24
Enzo Biochem, Inc., Interim Ratios 27
Enzo Biochem, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 29
Enzo Biochem, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013 30
Enzo Biochem, Inc., Recent Deals Summary 31
Currency Codes 36
Capital Market Ratios 36
Equity Ratios 37
Profitability Ratios 37
Cost Ratios 38
Liquidity Ratios 38
Leverage Ratios 39
Efficiency Ratios 39

List of Figures
Enzo Biochem, Inc., Pipeline Products by Therapy Area 9
Enzo Biochem, Inc., Pipeline Products by Development Phase 10
Enzo Biochem, Inc., Performance Chart (2008 - 2012) 26
Enzo Biochem, Inc., Ratio Charts 28
Enzo Biochem, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 29
Enzo Biochem, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013 30




...